Induction therapy and outcome of proliferative lupus nephritis in the top end of Northern Australia – a single centre study retrospective study

BACKGROUND: Lupus nephritis is a common manifestation of Systemic Lupus Erythematosus. Mycophenolate is recommended by guidelines for induction therapy in patients with proliferative lupus nephritis and nephrotic range proteinuria Class V lupus nephritis. Indigenous Australians suffer disproportiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chi, Goh, Kim Ling, Abeyaratne, Asanga, Priyadarshana, Kelum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254616/
https://www.ncbi.nlm.nih.gov/pubmed/35787253
http://dx.doi.org/10.1186/s12882-022-02849-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254616/
https://www.ncbi.nlm.nih.gov/pubmed/35787253
http://dx.doi.org/10.1186/s12882-022-02849-w

Ejemplares similares